nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—White blood cell count increased—Riluzole—amyotrophic lateral sclerosis	0.0965	0.108	CcSEcCtD
Lomitapide—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.052	0.058	CcSEcCtD
Lomitapide—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.0413	0.0461	CcSEcCtD
Lomitapide—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.0389	0.0434	CcSEcCtD
Lomitapide—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0354	0.0395	CcSEcCtD
Lomitapide—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.0279	0.0311	CcSEcCtD
Lomitapide—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0235	0.0262	CcSEcCtD
Lomitapide—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.0205	0.0228	CcSEcCtD
Lomitapide—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.0198	0.0221	CcSEcCtD
Lomitapide—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.0175	0.0195	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.0162	0.018	CcSEcCtD
Lomitapide—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.015	0.0167	CcSEcCtD
Lomitapide—Migraine—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0154	CcSEcCtD
Lomitapide—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0146	CcSEcCtD
Lomitapide—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.013	0.0145	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0141	CcSEcCtD
Lomitapide—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0139	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0138	CcSEcCtD
Lomitapide—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0136	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.0122	0.131	CbGpPWpGaD
Lomitapide—Influenza—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0135	CcSEcCtD
Lomitapide—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0132	CcSEcCtD
Lomitapide—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0116	0.013	CcSEcCtD
Lomitapide—MTTP—Chylomicron-mediated lipid transport—APOE—amyotrophic lateral sclerosis	0.0112	0.121	CbGpPWpGaD
Lomitapide—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.011	0.0123	CcSEcCtD
Lomitapide—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0121	CcSEcCtD
Lomitapide—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0121	CcSEcCtD
Lomitapide—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0115	CcSEcCtD
Lomitapide—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0114	CcSEcCtD
Lomitapide—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0113	CcSEcCtD
Lomitapide—Antrafenine—PTGS2—amyotrophic lateral sclerosis	0.00995	1	CrCbGaD
Lomitapide—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0096	0.0107	CcSEcCtD
Lomitapide—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00956	0.0107	CcSEcCtD
Lomitapide—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00953	0.0106	CcSEcCtD
Lomitapide—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00909	0.0101	CcSEcCtD
Lomitapide—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00903	0.0101	CcSEcCtD
Lomitapide—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00877	0.00977	CcSEcCtD
Lomitapide—Chills—Riluzole—amyotrophic lateral sclerosis	0.00873	0.00973	CcSEcCtD
Lomitapide—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00847	0.00944	CcSEcCtD
Lomitapide—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00834	0.0093	CcSEcCtD
Lomitapide—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00819	0.00913	CcSEcCtD
Lomitapide—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00814	0.00908	CcSEcCtD
Lomitapide—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00786	0.00876	CcSEcCtD
Lomitapide—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00783	0.00873	CcSEcCtD
Lomitapide—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00763	0.00851	CcSEcCtD
Lomitapide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00761	0.00848	CcSEcCtD
Lomitapide—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00748	0.00834	CcSEcCtD
Lomitapide—MTTP—Statin Pathway—APOE—amyotrophic lateral sclerosis	0.00733	0.0787	CbGpPWpGaD
Lomitapide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00721	0.00804	CcSEcCtD
Lomitapide—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00721	0.00804	CcSEcCtD
Lomitapide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00721	0.00804	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00716	0.00798	CcSEcCtD
Lomitapide—MTTP—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.00713	0.0765	CbGpPWpGaD
Lomitapide—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00712	0.00794	CcSEcCtD
Lomitapide—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00705	0.00786	CcSEcCtD
Lomitapide—Infection—Riluzole—amyotrophic lateral sclerosis	0.00686	0.00765	CcSEcCtD
Lomitapide—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00678	0.00756	CcSEcCtD
Lomitapide—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00671	0.00748	CcSEcCtD
Lomitapide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00668	0.00745	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0063	0.00702	CcSEcCtD
Lomitapide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.0062	0.00692	CcSEcCtD
Lomitapide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00614	0.00685	CcSEcCtD
Lomitapide—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00608	0.00678	CcSEcCtD
Lomitapide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00601	0.0067	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00597	0.00665	CcSEcCtD
Lomitapide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00596	0.00664	CcSEcCtD
Lomitapide—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00591	0.00659	CcSEcCtD
Lomitapide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00569	0.00635	CcSEcCtD
Lomitapide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00565	0.0063	CcSEcCtD
Lomitapide—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00546	0.00609	CcSEcCtD
Lomitapide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00546	0.00609	CcSEcCtD
Lomitapide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00496	0.00553	CcSEcCtD
Lomitapide—MTTP—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.00474	0.0509	CbGpPWpGaD
Lomitapide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00473	0.00527	CcSEcCtD
Lomitapide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00457	0.00509	CcSEcCtD
Lomitapide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00439	0.0049	CcSEcCtD
Lomitapide—Headache—Riluzole—amyotrophic lateral sclerosis	0.00433	0.00483	CcSEcCtD
Lomitapide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.0041	0.00458	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00401	0.0431	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00367	0.0394	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00341	0.0366	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.00324	0.0347	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00321	0.0344	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.0022	0.0236	CbGpPWpGaD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.0022	0.0236	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00179	0.0192	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00179	0.0192	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00167	0.0179	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00164	0.0175	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00152	0.0163	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00143	0.0153	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00135	0.0145	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—DAO—amyotrophic lateral sclerosis	0.00129	0.0139	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00098	0.0105	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSR—amyotrophic lateral sclerosis	0.000904	0.0097	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000823	0.00884	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000742	0.00797	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000678	0.00727	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000677	0.00727	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000635	0.00682	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000553	0.00593	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000543	0.00583	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000464	0.00498	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000437	0.00469	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000399	0.00428	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000386	0.00415	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00038	0.00408	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000369	0.00396	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000367	0.00394	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000351	0.00377	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000347	0.00372	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000317	0.0034	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—APOE—amyotrophic lateral sclerosis	0.000302	0.00324	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000268	0.00288	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000229	0.00246	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000226	0.00243	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000224	0.00241	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000216	0.00232	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000207	0.00222	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000204	0.00219	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000196	0.0021	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000196	0.0021	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.000194	0.00208	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000179	0.00192	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000173	0.00186	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000173	0.00186	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000166	0.00178	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000157	0.00169	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000156	0.00168	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000155	0.00166	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000155	0.00166	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000147	0.00157	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000141	0.00152	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000122	0.00131	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000121	0.00129	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000121	0.00129	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000113	0.00121	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00011	0.00118	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000107	0.00115	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000102	0.0011	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	9.89e-05	0.00106	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	9.64e-05	0.00103	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	9.58e-05	0.00103	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	8.71e-05	0.000935	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.12e-05	0.000872	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	7.24e-05	0.000777	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	6.6e-05	0.000709	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	6.09e-05	0.000654	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5e-05	0.000537	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.37e-05	0.000468	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.01e-05	0.000431	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.3e-05	0.000354	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.69e-05	0.000289	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.47e-05	0.000265	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.26e-05	0.000243	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.03e-05	0.000218	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.39e-05	0.00015	CbGpPWpGaD
